208 related articles for article (PubMed ID: 38510960)
1. Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients.
Rizzello F; Viciani E; Gionchetti P; Filippone E; Imbesi V; Melotti L; Dussias NK; Salice M; Santacroce B; Padella A; Velichevskaya A; Marcante A; Castagnetti A
Front Cell Infect Microbiol; 2024; 14():1352202. PubMed ID: 38510960
[TBL] [Abstract][Full Text] [Related]
2. Alterations in Fecal Fungal Microbiome of Patients With COVID-19 During Time of Hospitalization until Discharge.
Zuo T; Zhan H; Zhang F; Liu Q; Tso EYK; Lui GCY; Chen N; Li A; Lu W; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Oct; 159(4):1302-1310.e5. PubMed ID: 32598884
[TBL] [Abstract][Full Text] [Related]
3. Longitudinal alterations of the gut mycobiota and microbiota on COVID-19 severity.
Maeda Y; Motooka D; Kawasaki T; Oki H; Noda Y; Adachi Y; Niitsu T; Okamoto S; Tanaka K; Fukushima K; Amiya S; Hara R; Oguro-Igashira E; Matsuki T; Hirata H; Takeda Y; Kida H; Kumanogoh A; Nakamura S; Takeda K
BMC Infect Dis; 2022 Jun; 22(1):572. PubMed ID: 35751044
[TBL] [Abstract][Full Text] [Related]
4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
5. Fungal diversity in the gut microbiome of young South African children.
Nel Van Zyl K; Whitelaw AC; Hesseling AC; Seddon JA; Demers AM; Newton-Foot M
BMC Microbiol; 2022 Aug; 22(1):201. PubMed ID: 35978282
[TBL] [Abstract][Full Text] [Related]
6. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
[TBL] [Abstract][Full Text] [Related]
7. Prolonged Impairment of Short-Chain Fatty Acid and L-Isoleucine Biosynthesis in Gut Microbiome in Patients With COVID-19.
Zhang F; Wan Y; Zuo T; Yeoh YK; Liu Q; Zhang L; Zhan H; Lu W; Xu W; Lui GCY; Li AYL; Cheung CP; Wong CK; Chan PKS; Chan FKL; Ng SC
Gastroenterology; 2022 Feb; 162(2):548-561.e4. PubMed ID: 34687739
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
[TBL] [Abstract][Full Text] [Related]
9. Alteration of the gut microbiota following SARS-CoV-2 infection correlates with disease severity in hamsters.
Sencio V; Machelart A; Robil C; Benech N; Hoffmann E; Galbert C; Deryuter L; Heumel S; Hantute-Ghesquier A; Flourens A; Brodin P; Infanti F; Richard V; Dubuisson J; Grangette C; Sulpice T; Wolowczuk I; Pinet F; Prévot V; Belouzard S; Briand F; Duterque-Coquillaud M; Sokol H; Trottein F
Gut Microbes; 2022; 14(1):2018900. PubMed ID: 34965194
[TBL] [Abstract][Full Text] [Related]
10. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection in nonhuman primates alters the composition and functional activity of the gut microbiota.
Sokol H; Contreras V; Maisonnasse P; Desmons A; Delache B; Sencio V; Machelart A; Brisebarre A; Humbert L; Deryuter L; Gauliard E; Heumel S; Rainteau D; Dereuddre-Bosquet N; Menu E; Ho Tsong Fang R; Lamaziere A; Brot L; Wahl C; Oeuvray C; Rolhion N; Van Der Werf S; Ferreira S; Le Grand R; Trottein F
Gut Microbes; 2021; 13(1):1-19. PubMed ID: 33685349
[TBL] [Abstract][Full Text] [Related]
12. The Fungal Gut Microbiome Exhibits Reduced Diversity and Increased Relative Abundance of Ascomycota in Severe COVID-19 Illness and Distinct Interconnected Communities in SARS-CoV-2 Positive Patients.
Reinold J; Farahpour F; Schoerding AK; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Buer J; Witzke O; Westendorf AM; Kehrmann J
Front Cell Infect Microbiol; 2022; 12():848650. PubMed ID: 35521219
[TBL] [Abstract][Full Text] [Related]
13. Depicting SARS-CoV-2 faecal viral activity in association with gut microbiota composition in patients with COVID-19.
Zuo T; Liu Q; Zhang F; Lui GC; Tso EY; Yeoh YK; Chen Z; Boon SS; Chan FK; Chan PK; Ng SC
Gut; 2021 Feb; 70(2):276-284. PubMed ID: 32690600
[TBL] [Abstract][Full Text] [Related]
14. Metagenomic Next-Generation Sequencing of Nasopharyngeal Specimens Collected from Confirmed and Suspect COVID-19 Patients.
Mostafa HH; Fissel JA; Fanelli B; Bergman Y; Gniazdowski V; Dadlani M; Carroll KC; Colwell RR; Simner PJ
mBio; 2020 Nov; 11(6):. PubMed ID: 33219095
[TBL] [Abstract][Full Text] [Related]
15. The gut microbiome of COVID-19 recovered patients returns to uninfected status in a minority-dominated United States cohort.
Newsome RC; Gauthier J; Hernandez MC; Abraham GE; Robinson TO; Williams HB; Sloan M; Owings A; Laird H; Christian T; Pride Y; Wilson KJ; Hasan M; Parker A; Senitko M; Glover SC; Gharaibeh RZ; Jobin C
Gut Microbes; 2021; 13(1):1-15. PubMed ID: 34100340
[TBL] [Abstract][Full Text] [Related]
16. Neuropsychiatric Ramifications of COVID-19: Short-Chain Fatty Acid Deficiency and Disturbance of Microbiota-Gut-Brain Axis Signaling.
Sajdel-Sulkowska EM
Biomed Res Int; 2021; 2021():7880448. PubMed ID: 34651049
[TBL] [Abstract][Full Text] [Related]
17. Correlation Analysis between Gut Microbiota Alterations and the Cytokine Response in Patients with Coronavirus Disease during Hospitalization.
Mizutani T; Ishizaka A; Koga M; Ikeuchi K; Saito M; Adachi E; Yamayoshi S; Iwatsuki-Horimoto K; Yasuhara A; Kiyono H; Matano T; Suzuki Y; Tsutsumi T; Kawaoka Y; Yotsuyanagi H
Microbiol Spectr; 2022 Apr; 10(2):e0168921. PubMed ID: 35254122
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic, Prognostic, and Therapeutic Roles of Gut Microbiota in COVID-19: A Comprehensive Systematic Review.
Farsi Y; Tahvildari A; Arbabi M; Vazife F; Sechi LA; Shahidi Bonjar AH; Jamshidi P; Nasiri MJ; Mirsaeidi M
Front Cell Infect Microbiol; 2022; 12():804644. PubMed ID: 35310853
[TBL] [Abstract][Full Text] [Related]
19. Nutritional Modulation of Gut Microbiota Alleviates Severe Gastrointestinal Symptoms in a Patient with Post-Acute COVID-19 Syndrome.
Wang Y; Wu G; Zhao L; Wang W
mBio; 2022 Apr; 13(2):e0380121. PubMed ID: 35254129
[TBL] [Abstract][Full Text] [Related]
20. A Pro-Inflammatory Gut Microbiome Characterizes SARS-CoV-2 Infected Patients and a Reduction in the Connectivity of an Anti-Inflammatory Bacterial Network Associates With Severe COVID-19.
Reinold J; Farahpour F; Fehring C; Dolff S; Konik M; Korth J; van Baal L; Hoffmann D; Buer J; Witzke O; Westendorf AM; Kehrmann J
Front Cell Infect Microbiol; 2021; 11():747816. PubMed ID: 34869058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
